CUREVAC NV (5CV.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:5CV - NL0015436031 - Common Stock
4.384 EUR
-0.02 (-0.41%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 70.74M | 535.18M | 53.76M | 67.40M | 103.00M | |||
| Cost Of Goods | 4.95M | 105.83M | 116.28M | 159.00M | 238.20M | |||
| Gross Profit | 65.79M | 429.35M | -62.52M | -91.60M | -135.20M | |||
| Operating Expenses | -84.18M | 251.67M | 208.36M | 133.40M | 343.50M | |||
| Research and Development | 146.39M | 141.44M | 107.19M | 53.90M | 811.60M | |||
| Selling, General, and Administrative Expenses | 83.03M | 66.32M | 81.79M | 95.30M | 93.20M | |||
| Operating Income | 149.98M | 177.68M | -270.88M | -225.00M | -478.70M | |||
| Interest Income/Expense | 7.42M | 13.20M | 14.24M | 300.00K | -200.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | -3.32M | -24.50M | 66.40M | |||
| Income Before Taxes | 157.40M | 190.88M | -259.97M | -249.20M | -412.50M | |||
| Income Tax | 28.57M | 28.70M | 198.00K | -100.00K | -800.00K | |||
| Net Income | 128.82M | 162.19M | -260.17M | -249.00M | -411.70M | |||
| EBITDA | 167.63M | 196.49M | -247.50M | -201.30M | -463.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.57 | 0.72 | -1.18 | -1.28 | -2.20 | |||
| Non GAAP EPS | 0.58 | 0.73 | -1.18 | -1.24 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 93.01% | 80.23% | -116.30% | -135.91% | -131.26% | |||
| Profit Margin | 182.11% | 30.30% | -483.96% | -369.44% | -399.71% | |||
| Operating Profit Margin | 212.01% | 33.20% | -503.89% | -333.83% | -464.76% | |||
All data in EUR